Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Efficacy of RC48 Combined With Toripalimab in Treatment of Cisplatin Ineligible MIBC

NCT06341400 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT06341400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06341400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Efficacy of RC48 Combined With Toripalimab in Treatment of Cisplatin Ineligible MIBC
Lead sponsor
Zhujiang Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 19, 2024
Completion date
May 1, 2029
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, muscle-invasive bladder carcinoma